# Prevalence of Thrombophilic Gene Polymorphism (MTHFR C677T) in COVID-19patients

> **NCT05679414** · — · COMPLETED · sponsor: **Ain Shams University** · enrollment: 46 (actual)

## Conditions studied

- COVID 19 Associated Coagulopathy

## Interventions

- **DIAGNOSTIC_TEST:** RT- PCR of 2 ml EDTA blood sample to determine MTHFR C677T genotypes

## Key facts

- **NCT ID:** NCT05679414
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-11
- **Primary completion:** 2022-11-30
- **Final completion:** 2022-11-30
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2023-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05679414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05679414, "Prevalence of Thrombophilic Gene Polymorphism (MTHFR C677T) in COVID-19patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05679414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*